Clinical Trials Browser

OTHER × Thyroid Diseases × temsirolimus × Clear all

NCT01025453 2018-08-15

Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer

Phase 2 Completed

37 enrolled 11 charts

Thyroid Diseases, Thyroid Neoplasms